HR
MRVI icon

Howe & Rusling’s Maravai LifeSciences MRVI Stock Holding History

Howe & Rusling’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-110
Closed -$3K – 762
2022
Q3 		$3K Hold
110
– – ﹤0.01% 795
2022
Q2 		$3K Buy
110
+9
+9% +$285 ﹤0.01% 799
2022
Q1 		$4K Sell
101
-12
-11% -$402 ﹤0.01% 726
2021
Q4 		$5K Hold
113
– – ﹤0.01% 678
2021
Q3 		$6K Buy
113
+17
+18% +$829 ﹤0.01% 597
2021
Q2 		$4K Buy
96
+30
+45% +$1.16K ﹤0.01% 682
2021
Q1 		$2K Sell
66
-5
-7% -$166 ﹤0.01% 824
2020
Q4 		$2K Buy
+71
New +$1.98K ﹤0.01% 817

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Howe & Rusling's MRVI Position: Q4 2022 in Review

Howe & Rusling sold out of Maravai LifeSciences (MRVI) in Q4 2022, closing a stake of 110 shares — an estimated $3K sold.

Howe & Rusling first reported a position in MRVI in Q4 2020 and held it in 8 quarters. The position peaked at $6K in Q3 2021. 212 funds tracked by Wall St. Rank hold MRVI as of Q4 2022.

  • Howe & Rusling reported no remaining Maravai LifeSciences position as of Q4 2022 after selling out during the quarter.
  • Howe & Rusling sold 110 Maravai LifeSciences shares in Q4 2022, an estimated $3K.
  • Howe & Rusling first reported a position in Maravai LifeSciences in Q4 2020 and held it in 8 quarters.
  • Howe & Rusling's Maravai LifeSciences position peaked at $6K in Q3 2021.
  • 212 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2022.

Based on Howe & Rusling's 13F filing for Q4 2022, filed 15 Feb 2023.